Main state industrial policy measures for the pharmaceutical industry of the Russian Federation
- 28 February 2023
- journal article
- research article
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 2023(1)
Abstract
Due to the changes in the modern world, it is necessary to develop the domestic pharmaceutical industry, which is a task especially important in the context of implementation of the import substitution policy. The article classifies the main measures the state industrial policy has for the pharmaceutical industry; these measures cover informational and consulting aspects, research and technical parts, innovations and economic matters. Practical actions and their possible consequences are considered for each group of the industrial policy measures: encouragement of domestic consumption, regulation of imports, stimulation and support of exports, stimulation of technological development, public-private partnerships, support of the development of intersectoral territorial production complexes (clusters), direct state support of investment activities, tax incentives for investors.Keywords
This publication has 10 references indexed in Scilit:
- Состояние школ духовного ведомства на территории Костромской губернии в конце XIX - начале XX столетия: общероссийские закономерности и местная спецификаVestnik Yaroslavskogo gosudarstvennogo universiteta im. P. G. Demidova. Seriya gumanitarnye nauki, 2022
- Research on government subsidy strategies for new drug R&D considering spillover effectsPLOS ONE, 2022
- Drug importation: limitations of current proposals and opportunities for improvementBlood Cancer Journal, 2021
- Compulsory licensing in pharmaceutical industry: current state of affairs and prospectsBulletin of Russian State Medical University, 2021
- Manufacturing Revolutions: Industrial Policy and Industrialization in South KoreaSSRN Electronic Journal, 2021
- The new industrial policy: A chance for the BRICS countriesBRICS Journal of Economics, 2020
- Industrial policy, structural transformation and economic growth: evidence from ChinaFrontiers of Business Research in China, 2019
- An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?Nature Biotechnology, 2019
- Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?Journal of Translational Medicine, 2018
- Building a Balanced Industrial Policy: Issues of Structuring Goals, Tasks and ToolsVoprosy Ekonomiki, 2012